TELA Bio, Inc. Analyst EPS Estimates
Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 1 | -$0.49 | -$0.49 | -$0.49 |
Q2 2024 | 1 | -$0.46 | -$0.46 | -$0.46 |
Q3 2024 | 3 | -$0.47 | -$0.34 | -$0.40 |
Q4 2024 | 1 | -$0.27 | -$0.27 | -$0.27 |
Q1 2025 | 2 | -$0.33 | -$0.33 | -$0.33 |
Q2 2025 | 2 | -$0.27 | -$0.27 | -$0.27 |
Q3 2025 | 2 | -$0.28 | -$0.28 | -$0.28 |
Q4 2025 | 2 | -$0.23 | -$0.23 | -$0.23 |
Q1 2026 | 1 | -$0.15 | -$0.15 | -$0.15 |
Q2 2026 | 1 | -$0.07 | -$0.07 | -$0.07 |
Q3 2026 | 1 | -$0.06 | -$0.06 | -$0.06 |
Q4 2026 | 1 | $0.01 | $0.01 | $0.01 |
TELA Bio, Inc. Earnings Date And Information
TELA Bio, Inc. last posted its earnings results on Monday, August 12th, 2024. The company reported $-0.51 earnings per share for the quarter, missing analysts' consensus estimates of $-0.45 by $0.06. The company had revenue of 16.09 M for the quarter and had revenue of 58.45 M for the year. TELA Bio, Inc. has generated $-2 earnings per share over the last year ($-2.04 diluted earnings per share) and currently has a price-to-earnings ratio of -1.88. TELA Bio, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 7th, 2024 based on prior year's report dates.
TELA Bio, Inc. Earnings History by Quarter
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
08/13/2024 | Q2 2024 | -$0.51 | $18.45 M | $16.09 M | ||
05/10/2024 | Q1 2024 | -$0.23 | $16.60 M | |||
03/22/2024 | Q4 2023 | -$0.53 | $17.00 M | |||
11/13/2023 | Q3 2023 | -$0.45 | $16.20 M | $15.05 M | ||
08/10/2023 | Q2 2023 | -$0.46 | $14.39 M | $14.49 M | ||
05/11/2023 | Q1 2023 | -$0.51 | -$0.73 | -0.22 | $11.91 M | |
03/23/2023 | Q4 2022 | -$0.51 | $11.62 M | |||
11/10/2022 | Q3 2022 | -$0.71 | $10.86 M | $11.16 M | ||
08/11/2022 | Q2 2022 | -$0.92 | $10.12 M | $10.41 M | ||
05/11/2022 | Q1 2022 | -$0.82 | $8.23 M | |||
03/23/2022 | Q4 2021 | -$0.59 | $8.37 M | |||
11/12/2021 | Q3 2021 | -$0.57 | $7.55 M | $7.65 M | ||
08/12/2021 | Q2 2021 | -$0.57 | $6.31 M | $7.56 M | ||
05/14/2021 | Q1 2021 | -$0.56 | $5.88 M | |||
03/25/2021 | Q4 2020 | -$0.54 | $5.67 M | |||
11/12/2020 | Q3 2020 | -$0.53 | $4.57 M | $5.31 M | ||
08/13/2020 | Q2 2020 | -$0.53 | $1.94 M | $3.51 M | ||
05/15/2020 | Q1 2020 | -$0.63 | $3.73 M | |||
03/30/2020 | Q4 2019 | -$1.07 | $4.86 M | |||
12/18/2019 | Q3 2019 | -$0.44 | $3.94 M | $3.97 M |
TELA Bio, Inc. Earnings: Frequently Asked Questions
-
When is TELA Bio, Inc.'s earnings date?
TELA Bio, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 7th, 2024 based off last year's report dates.
-
How can I listen to TELA Bio, Inc.'s earnings conference call?
The conference call for TELA Bio, Inc.'s latest earnings report can be listened to online.
-
How can I read TELA Bio, Inc.'s conference call transcript?
The conference call transcript for TELA Bio, Inc.'s latest earnings report can be read online.
-
How much revenue does TELA Bio, Inc. generate each year?
TELA Bio, Inc. (:TELA) has a recorded annual revenue of $58.45 M.
-
How much profit does TELA Bio, Inc. generate each year?
TELA Bio, Inc. (:TELA) has a recorded net income of $58.45 M. TELA Bio, Inc. has generated $-2.04 earnings per share over the last four quarters.
-
What is TELA Bio, Inc.'s price-to-earnings ratio?
TELA Bio, Inc. (:TELA) has a price-to-earnings ratio of -1.88 and price/earnings-to-growth ratio is 0.63.